Title: SENATE BILL 773 By: Gollihare
Official Title: SENATE BILL 773 By: Gollihare
Number of Sections: 44
Source: versions - Introduced
Media Type: application/pdf
Strikethrough Detection: 14 sections found

================================================================================

Section 1:
1
STATE OF OKLAHOMA
1
2
1st Session of the 60th Legislature (2025)
2
3
3
4
4
5
5
6
AS INTRODUCED
6
7
An Act relating to pharmacy benefit managers;
7
amending 36 O.S. 2021, Sections 6960, as last amended
8
by Section 1, Chapter 306, O.S.L. 2024, 6962, as last
8
amended by Section 2, Chapter 306, O.S.L. 2024, and
9
6965, as last amended by Section 3, Chapter 306,
9
O.S.L. 2024 (36 O.S. Supp. 2024, Sections 6960, 6962,
10
and 6965), which relate to definitions, compliance
10
review, and power and authority to investigate,
11
examine, and enforce; modifying definitions;
11
prohibiting certain circumstances; requiring
12
nonpayment under providing venue for certain court
12
proceeding; allowing Attorney General to obtain
13
certain information; extending certain duties; and
13
providing an effective date.
14
14
15
15
16
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
16
17

Section 2:
SECTION 1. AMENDATORY 36 O.S. 2021, Section 6960, as
17
18
last amended by Section 1, Chapter 306, O.S.L. 2024 (36 O.S. Supp.
18
19
2024, Section 6960), is amended to read as follows:
19
20

Section 3:
Section 6960. A. For purposes of the Patient’s Right to
20
21
Pharmacy Choice Act:
21
22

Section 4:
1. “Covered entity” means a nonprofit hospital or medical
22
23
service organization, for-profit hospital or medical service
23
24
organization, insurer, health benefit plan, health maintenance
24
Req. No. 697 Page 1
1
organization, health program administered by the state in the
1
2
capacity of providing health coverage, or an employer, labor union,
2
3
or other group of persons that provides health coverage to persons
3
4
in this state. This term does not include a health plan that
4
5
provides coverage only for accidental injury, specified disease,
5
6
hospital indemnity, disability income, or other limited benefit
6
7
health insurance policies and contracts that do not include
7
8
prescription drug coverage;
8
9

Section 5:
2. “Health insurer” means any corporation, association, benefit
9
10
society, exchange, partnership or individual licensed by the
10
11
Oklahoma Insurance Code;
11
12

Section 6:
3. “Health insurer payor” means a health insurance company,
12
13
health maintenance organization, union, hospital and medical
13
14
services organization or any entity providing or administering a
14
15
self-funded health benefit plan;
15
16

Section 7:
4. “Mail-order pharmacy” means a pharmacy licensed by this
16
17
state that primarily dispenses and delivers covered drugs via common
17
18
carrier;
18
19

Section 8:
5. “Pharmacy benefits manager” or “PBM” means a person,
19
20
business, or other entity that performs pharmacy benefits
20
21
management. The term shall include a person or entity acting on
21
22
behalf of a PBM in a contractual or employment relationship in the
22
23
performance of pharmacy benefits management for a managed care
23
24
company, nonprofit hospital, medical service organization, insurance
24
Req. No. 697 Page 2
1
company, third-party payor or a health program administered by a
1
2
department of this state;
2
3

Section 9:
6. “Pharmacy benefits management” means a service provided to
3
4
covered entities to facilitate the provisions of prescription drug
4
5
benefits to covered individuals within the state, including, but not
5
6
limited to, negotiating pricing and other terms with drug
6
7
manufacturers and providers. Pharmacy benefits management may
7
8
include any or all of the following services:
8
9
a. claims processing, retail network management, and
9
10
payment of claims to pharmacies for prescription drugs
10
11
dispensed to covered individuals,
11
12
b. administration or management of pharmacy discount
12
13
cards or programs,
13
14
c. clinical formulary development and management
14
15
services, or
15
16
d. c. rebate contracting and administration;
16
17

Section 10:
7. “Provider” means a pharmacy, as defined in Section 353.1 of
17
18
Title 59 of the Oklahoma Statutes or an agent or representative of a
18
19
pharmacy;
19
20

Section 11:
8. “Retail pharmacy network” means retail pharmacy providers
20
21
contracted with a PBM in which the pharmacy primarily fills and
21
22
sells prescriptions via a retail, storefront location;
22
23
23
24
24
Req. No. 697 Page 3
1

Section 12:
9. “Rural service area” means a five-digit ZIP code in which
1
2
the population density is less than one thousand (1,000) individuals
2
3
per square mile;
3
4

Section 13:
10. “Spread pricing” means a prescription drug pricing model
4
5
utilized by a pharmacy benefits manager in which the PBM charges a
5
6
health benefit plan a contracted price for prescription drugs that
6
7
differs from the amount the PBM directly or indirectly pays the
7
8
pharmacy or pharmacist for providing pharmacy services;
8
9

Section 14:
11. “Suburban service area” means a five-digit ZIP code in
9
10
which the population density is between one thousand (1,000) and
10
11
three thousand (3,000) individuals per square mile; and
11
12

Section 15:
12. “Urban service area” means a five-digit ZIP code in which
12
13
the population density is greater than three thousand (3,000)
13
14
individuals per square mile.
14
15
B. Nothing in the definitions of pharmacy benefits manager or
15
16
pharmacy benefits management as such terms are defined in the
16
17
Patient’s Right to Pharmacy Choice Act, the Pharmacy Audit Integrity
17
18
Act, or Sections 357 through 360 of Title 59 of the Oklahoma
18
19
Statutes shall be construed to deem the following entities to be a
19
20
pharmacy benefits manager:
20
21

Section 16:
1. An employer of its own self-funded health benefit plan,
21
22
except, to the extent permitted by applicable law, where the
22
23
employer without the utilization of a third party and unrelated to
23
24
the employer’s own pharmacy:
24
Req. No. 697 Page 4
1
a. negotiates directly with drug manufacturers,
1
2
b. processes claims on behalf of its members, or
2
3
c. manages its own retail network of pharmacies; or
3
4

Section 17:
2. A pharmacy that provides a patient with a discount card or
4
5
program that is for exclusive use at the pharmacy offering the
5
6
discount.
6
7

Section 18:
SECTION 2. AMENDATORY 36 O.S. 2021, Section 6962, as
7
8
last amended by Section 2, Chapter 306, O.S.L. 2024 (36 O.S. Supp.
8
9
2024, Section 6962), is amended to read as follows:
9
10

Section 19:
Section 6962. A. The Attorney General shall review and approve
10
11
retail pharmacy network access for all pharmacy benefits managers
11
12
(PBMs) to ensure compliance with Section 6961 of this title.
12
13
B. A PBM, or an agent of a PBM, shall not:
13
14

Section 20:
1. Cause or knowingly permit the use of advertisement,
14
15
promotion, solicitation, representation, proposal or offer that is
15
16
untrue, deceptive or misleading;
16
17

Section 21:
2. Charge a pharmacist or pharmacy a fee related to the
17
18
adjudication of a claim including without limitation a fee for:
18
19
a. the submission of a claim,
19
20
b. enrollment or participation in a retail pharmacy
20
21
network, or
21
22
c. the development or management of claims processing
22
23
services or claims payment services related to
23
24
participation in a retail pharmacy network;
24
Req. No. 697 Page 5
1

Section 22:
3. Reimburse a pharmacy or pharmacist in the state an amount
1
2
less than the amount that the PBM reimburses a pharmacy owned by or
2
3
under common ownership with a PBM for providing the same covered
3
4
services. The reimbursement amount paid to the pharmacy shall be
4
5
equal to the reimbursement amount calculated on a per-unit basis
5
6
using the same generic product identifier or generic code number
6
7
paid to the PBM-owned or PBM-affiliated pharmacy;
7
8

Section 23:
4. Deny a provider the opportunity to participate in any
8
9
pharmacy network at preferred participation status if the provider
9
10
is willing to accept the terms and conditions that the PBM has
10
11
established for other providers as a condition of preferred network
11
12
participation status;
12
13

Section 24:
5. Deny, limit or terminate a provider’s contract based on
13
14
employment status of any employee who has an active license to
14
15
dispense, despite probation status, with the State Board of
15
16
Pharmacy;
16
17

Section 25:
6. Retroactively deny or reduce reimbursement for a covered
17
18
service claim after returning a paid claim response as part of the
18
19
adjudication of the claim, unless:
19
20
a. the original claim was submitted fraudulently, or
20
21
b. to correct errors identified in an audit, so long as
21
22
the audit was conducted in compliance with Sections
22
23

Section 26:
356.2 and 356.3 of Title 59 of the Oklahoma Statutes;
23
24
24
Req. No. 697 Page 6
1

Section 27:
7. Fail to make any payment due to a pharmacy or pharmacist for
1
2
covered services properly rendered in the event a PBM terminates a
2
3
provider from a pharmacy benefits manager network;
3
4

Section 28:
8. Fail to make any payment due to a pharmacy or pharmacist for
4
5
covered services properly rendered in the event a PBM terminates its
5
6
contract with a plan sponsor or insurer;
6
7

Section 29:
9. Conduct or practice spread pricing, as defined in Section
7
8
6960 of this title, in this state; or
8
9

Section 30:
9. 10. Charge a pharmacist or pharmacy a fee related to
9
10
participation in a retail pharmacy network including but not limited
10
11
to the following:
11
12
a. an application fee,
12
13
b. an enrollment or participation fee,
13
14
c. a credentialing or re-credentialing fee,
14
15
d. a change of ownership fee, or
15
16
e. a fee for the development or management of claims
16
17
processing services or claims payment services.
17
18
C. The prohibitions under this section shall apply to contracts
18
19
between pharmacy benefits managers and providers for participation
19
20
in retail pharmacy networks.
20
21

Section 31:
1. A PBM contract shall:
21
22
a. not restrict, directly or indirectly, any pharmacy
22
23
that dispenses a prescription drug from informing, or
23
24
penalize such pharmacy for informing, an individual of
24
Req. No. 697 Page 7
1
any differential between the individual’s out-of-
1
2
pocket cost or coverage with respect to acquisition of
2
3
the drug and the amount an individual would pay to
3
4
purchase the drug directly, and
4
5
b. ensure that any entity that provides pharmacy benefits
5
6
management services under a contract with any such
6
7
health plan or health insurance coverage does not,
7
8
with respect to such plan or coverage, restrict,
8
9
directly or indirectly, a pharmacy that dispenses a
9
10
prescription drug from informing, or penalize such
10
11
pharmacy for informing, a covered individual of any
11
12
differential between the individual’s out-of-pocket
12
13
cost under the plan or coverage with respect to
13
14
acquisition of the drug and the amount an individual
14
15
would pay for acquisition of the drug without using
15
16
any health plan or health insurance coverage.
16
17

Section 32:
2. A pharmacy benefits manager’s contract with a provider shall
17
18
not prohibit, restrict, or limit disclosure of information or
18
19
documents to the Attorney General, law enforcement or state and
19
20
federal governmental officials investigating or examining a
20
21
complaint or conducting a review of a pharmacy benefits manager’s
21
22
compliance with the requirements under the Patient’s Right to
22
23
Pharmacy Choice Act, the Pharmacy Audit Integrity Act, and Sections
23
24
357 through 360 of Title 59 of the Oklahoma Statutes.
24
Req. No. 697 Page 8
1
D. A pharmacy benefits manager shall:
1
2

Section 33:
1. Establish and maintain an electronic claim inquiry
2
3
processing system using the National Council for Prescription Drug
3
4
Programs’ current standards to communicate information to pharmacies
4
5
submitting claim inquiries;
5
6

Section 34:
2. Fully disclose to insurers, self-funded employers, unions or
6
7
other PBM clients the existence of the respective aggregate
7
8
prescription drug discounts, rebates received from drug
8
9
manufacturers and pharmacy audit recoupments;
9
10

Section 35:
3. Provide the Attorney General, insurers, self-funded employer
10
11
plans and unions unrestricted audit rights of and access to the
11
12
respective PBM pharmaceutical manufacturer and provider contracts,
12
13
plan utilization data, plan pricing data, pharmacy utilization data
13
14
and pharmacy pricing data;
14
15

Section 36:
4. Maintain, for no less than three (3) years, documentation of
15
16
all network development activities including but not limited to
16
17
contract negotiations and any denials to providers to join networks.
17
18
This documentation shall be made available to the Attorney General
18
19
upon request; and
19
20

Section 37:
5. Report to the Attorney General, on a quarterly basis for
20
21
each health insurer payor, on the following information:
21
22
a. the aggregate amount of rebates received by the PBM,
22
23
b. the aggregate amount of rebates distributed to the
23
24
appropriate health insurer payor,
24
Req. No. 697 Page 9
1
c. the aggregate amount of rebates passed on to the
1
2
enrollees of each health insurer payor at the point of
2
3
sale that reduced the applicable deductible,
3
4
copayment, coinsure or other cost sharing amount of
4
5
the enrollee,
5
6
d. the individual and aggregate amount paid by the health
6
7
insurer payor to the PBM for pharmacy services
7
8
itemized by pharmacy, drug product and service
8
9
provided, and
9
10
e. the individual and aggregate amount a PBM paid a
10
11
provider for pharmacy services itemized by pharmacy,
11
12
drug product and service provided.
12
13
E. Nothing in the Patient’s Right to Pharmacy Choice Act shall
13
14
prohibit the Attorney General from requesting and obtaining detailed
14
15
data, including raw data, in response to the information provided by
15
16
a PBM in the quarterly reports required by this section. The
16
17
Attorney General may alter the frequency of the reports required by
17
18
this section at his or her sole discretion.
18
19
F. The Attorney General may promulgate rules to implement the
19
20
provisions of the Patient’s Right to Pharmacy Choice Act, the
20
21
Pharmacy Audit Integrity Act, and Sections 357 through 360 of Title
21
22
59 of the Oklahoma Statutes.
22
23
23
24
24
Req. No. 697 Page 10
1

Section 38:
SECTION 3. AMENDATORY 36 O.S. 2021, Section 6965, as
1
2
last amended by Section 3, Chapter 306, O.S.L. 2024 (36 O.S. Supp.
2
3
2024, Section 6965), is amended to read as follows:
3
4

Section 39:
Section 6965. A. The Attorney General shall have power and
4
5
authority to examine and investigate the affairs of every pharmacy
5
6
benefits manager (PBM) engaged in pharmacy benefits management in
6
7
this state in order to determine whether such entity is in
7
8
compliance with the Patient’s Right to Pharmacy Choice Act, the
8
9
Pharmacy Audit Integrity Act, and Sections 357 through 360 of Title
9
10
59 of the Oklahoma Statutes.
10
11
B. The Attorney General shall have the power and authority to
11
12
subpoena witnesses and records, whether prior to or during an
12
13
investigation or prosecution of a complaint, from any relevant
13
14
entity or persons to ensure compliance with the Patient’s Right to
14
15
Pharmacy Choice Act, the Pharmacy Audit Integrity Act, and Sections
15
16
357 through 360 of Title 59 of the Oklahoma Statutes.
16
17
C. All PBM files and records shall be subject to examination by
17
18
the Attorney General or by duly appointed designees. The Attorney
18
19
General, authorized employees and examiners shall have access to any
19
20
of a PBM’s files and records that may relate to a particular
20
21
complaint under investigation or to an inquiry or examination by the
21
22
Attorney General.
22
23
D. Every officer, director, employee or agent of the PBM, upon
23
24
receipt of any inquiry from the Attorney General, shall, within
24
Req. No. 697 Page 11
1
twenty (20) days from the date the inquiry is sent, furnish the
1
2
Attorney General with an adequate response to the inquiry.
2
3
E. When making an examination under this section, the Attorney
3
4
General may retain subject matter experts, attorneys, appraisers,
4
5
independent actuaries, independent certified public accountants or
5
6
an accounting firm or individual holding a permit to practice public
6
7
accounting, certified financial examiners or other professionals and
7
8
specialists as examiners, the cost of which shall be borne by the
8
9
PBM that is the subject of the examination.
9
10
F. 1. Protected health information (PHI) held by a PBM shall
10
11
be provided at the request of the Attorney General for the purpose
11
12
of conducting investigations into potential violations of state laws
12
13
and regulations related to the PBM. Disclosure of protected health
13
14
information shall be limited to the extent necessary for the
14
15
investigation and enforcement of state law.
15
16

Section 40:
2. All disclosures of protected health information shall be
16
17
made in compliance with all applicable federal and state privacy
17
18
laws, including the Health Insurance Portability and Accountability
18
19
Act of 1996 (HIPAA), and other relevant laws protecting the privacy
19
20
and confidentiality of health information.
20
21

Section 41:
3. Any protected health information obtained for an
21
22
investigation shall be handled and maintained per applicable federal
22
23
and state privacy laws and regulations, including HIPAA.
23
24
24
Req. No. 697 Page 12
1

Section 42:
4. Unauthorized disclosure of protected health information
1
2
obtained during an investigation is strictly prohibited and subject
2
3
to legal penalties.
3
4
G. 1. If the Attorney General, after notice and opportunity
4
5
for hearing, finds that any PBM operating within this state has not
5
6
fully cooperated with an investigation or inquiry conducted by the
6
7
Attorney General related to compliance with the Patient’s Right to
7
8
Pharmacy Choice Act, the Pharmacy Audit Integrity Act, and Sections
8
9
357 through 360 of Title 59 of the Oklahoma Statutes, the Attorney
9
10
General may instruct the Insurance Commissioner that the PBM be
10
11
censured or his or her license be suspended or revoked. If the
11
12
Attorney General makes such instruction, the Commissioner shall
12
13
enforce the instructed action within thirty (30) days.
13
14

Section 43:
2. In addition to or in lieu of any censure, suspension, or
14
15
revocation by the Commissioner, the Attorney General may levy a
15
16
civil or administrative fine not less than One Hundred Dollars
16
17
($100.00) and not greater than Ten Thousand Dollars ($10,000.00) for
17
18
each violation of this subsection and assess any other penalty or
18
19
remedy authorized by this act. For purposes of this section, each
19
20
day a PBM fails to comply with an investigation or inquiry may be
20
21
considered a separate violation.
21
22
H. The proper venue to compel compliance with a subpoena of a
22
23
person or entity under this section shall be in the Oklahoma County
23
24
District Court.
24
Req. No. 697 Page 13
1
I. No provision of this state’s law shall be construed to
1
2
prohibit the Attorney General from obtaining any information or
2
3
documentation pertaining to prescription drug transactions
3
4
including, but not limited to, data, statements, testimonies,
4
5
contracts, communications, provider manuals, or any other
5
6
documentation or materials, whether related to discount programs,
6
7
loyalty programs, or otherwise. The duty to provide cooperation as
7
8
set forth in this section shall extend to all PBMs, insurers,
8
9
auditors, employers, vendors, or any other individual or entity
9
10
acting on behalf of or in collaboration with a PBM.
10
11

Section 44:
SECTION 4. This act shall become effective November 1, 2025.
11
12
12
13
60-1-697 CAD 1/19/2025 5:43:03 AM
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
21
21
22
22
23
23
24
24
Req. No. 697 Page 14
[DELETED:  P B G]
[DELETED:  P]
[DELETED:  P c a c]
[DELETED:  P]
[DELETED:  P n p m t e t]
[DELETED:  P t t]
[DELETED:  P a a a a a n]
[DELETED:  P e]
[DELETED:  P t t]
[DELETED:  P t t t]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P C 1]


================================================================================

Raw Text:
1
STATE OF OKLAHOMA
1
2
1st Session of the 60th Legislature (2025)
2
3
SENATE BILL 773 By: Gollihare
3
4
4
5
5
6
AS INTRODUCED
6
7
An Act relating to pharmacy benefit managers;
7
amending 36 O.S. 2021, Sections 6960, as last amended
8
by Section 1, Chapter 306, O.S.L. 2024, 6962, as last
8
amended by Section 2, Chapter 306, O.S.L. 2024, and
9
6965, as last amended by Section 3, Chapter 306,
9
O.S.L. 2024 (36 O.S. Supp. 2024, Sections 6960, 6962,
10
and 6965), which relate to definitions, compliance
10
review, and power and authority to investigate,
11
examine, and enforce; modifying definitions;
11
prohibiting certain circumstances; requiring
12
nonpayment under providing venue for certain court
12
proceeding; allowing Attorney General to obtain
13
certain information; extending certain duties; and
13
providing an effective date.
14
14
15
15
16
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
16
17
SECTION 1. AMENDATORY 36 O.S. 2021, Section 6960, as
17
18
last amended by Section 1, Chapter 306, O.S.L. 2024 (36 O.S. Supp.
18
19
2024, Section 6960), is amended to read as follows:
19
20
Section 6960. A. For purposes of the Patient’s Right to
20
21
Pharmacy Choice Act:
21
22
1. “Covered entity” means a nonprofit hospital or medical
22
23
service organization, for-profit hospital or medical service
23
24
organization, insurer, health benefit plan, health maintenance
24
Req. No. 697 Page 1

1
organization, health program administered by the state in the
1
2
capacity of providing health coverage, or an employer, labor union,
2
3
or other group of persons that provides health coverage to persons
3
4
in this state. This term does not include a health plan that
4
5
provides coverage only for accidental injury, specified disease,
5
6
hospital indemnity, disability income, or other limited benefit
6
7
health insurance policies and contracts that do not include
7
8
prescription drug coverage;
8
9
2. “Health insurer” means any corporation, association, benefit
9
10
society, exchange, partnership or individual licensed by the
10
11
Oklahoma Insurance Code;
11
12
3. “Health insurer payor” means a health insurance company,
12
13
health maintenance organization, union, hospital and medical
13
14
services organization or any entity providing or administering a
14
15
self-funded health benefit plan;
15
16
4. “Mail-order pharmacy” means a pharmacy licensed by this
16
17
state that primarily dispenses and delivers covered drugs via common
17
18
carrier;
18
19
5. “Pharmacy benefits manager” or “PBM” means a person,
19
20
business, or other entity that performs pharmacy benefits
20
21
management. The term shall include a person or entity acting on
21
22
behalf of a PBM in a contractual or employment relationship in the
22
23
performance of pharmacy benefits management for a managed care
23
24
company, nonprofit hospital, medical service organization, insurance
24
Req. No. 697 Page 2

1
company, third-party payor or a health program administered by a
1
2
department of this state;
2
3
6. “Pharmacy benefits management” means a service provided to
3
4
covered entities to facilitate the provisions of prescription drug
4
5
benefits to covered individuals within the state, including, but not
5
6
limited to, negotiating pricing and other terms with drug
6
7
manufacturers and providers. Pharmacy benefits management may
7
8
include any or all of the following services:
8
9
a. claims processing, retail network management, and
9
10
payment of claims to pharmacies for prescription drugs
10
11
dispensed to covered individuals,
11
12
b. administration or management of pharmacy discount
12
13
cards or programs,
13
14
c. clinical formulary development and management
14
15
services, or
15
16
d. c. rebate contracting and administration;
16
17
7. “Provider” means a pharmacy, as defined in Section 353.1 of
17
18
Title 59 of the Oklahoma Statutes or an agent or representative of a
18
19
pharmacy;
19
20
8. “Retail pharmacy network” means retail pharmacy providers
20
21
contracted with a PBM in which the pharmacy primarily fills and
21
22
sells prescriptions via a retail, storefront location;
22
23
23
24
24
Req. No. 697 Page 3

1
9. “Rural service area” means a five-digit ZIP code in which
1
2
the population density is less than one thousand (1,000) individuals
2
3
per square mile;
3
4
10. “Spread pricing” means a prescription drug pricing model
4
5
utilized by a pharmacy benefits manager in which the PBM charges a
5
6
health benefit plan a contracted price for prescription drugs that
6
7
differs from the amount the PBM directly or indirectly pays the
7
8
pharmacy or pharmacist for providing pharmacy services;
8
9
11. “Suburban service area” means a five-digit ZIP code in
9
10
which the population density is between one thousand (1,000) and
10
11
three thousand (3,000) individuals per square mile; and
11
12
12. “Urban service area” means a five-digit ZIP code in which
12
13
the population density is greater than three thousand (3,000)
13
14
individuals per square mile.
14
15
B. Nothing in the definitions of pharmacy benefits manager or
15
16
pharmacy benefits management as such terms are defined in the
16
17
Patient’s Right to Pharmacy Choice Act, the Pharmacy Audit Integrity
17
18
Act, or Sections 357 through 360 of Title 59 of the Oklahoma
18
19
Statutes shall be construed to deem the following entities to be a
19
20
pharmacy benefits manager:
20
21
1. An employer of its own self-funded health benefit plan,
21
22
except, to the extent permitted by applicable law, where the
22
23
employer without the utilization of a third party and unrelated to
23
24
the employer’s own pharmacy:
24
Req. No. 697 Page 4

1
a. negotiates directly with drug manufacturers,
1
2
b. processes claims on behalf of its members, or
2
3
c. manages its own retail network of pharmacies; or
3
4
2. A pharmacy that provides a patient with a discount card or
4
5
program that is for exclusive use at the pharmacy offering the
5
6
discount.
6
7
SECTION 2. AMENDATORY 36 O.S. 2021, Section 6962, as
7
8
last amended by Section 2, Chapter 306, O.S.L. 2024 (36 O.S. Supp.
8
9
2024, Section 6962), is amended to read as follows:
9
10
Section 6962. A. The Attorney General shall review and approve
10
11
retail pharmacy network access for all pharmacy benefits managers
11
12
(PBMs) to ensure compliance with Section 6961 of this title.
12
13
B. A PBM, or an agent of a PBM, shall not:
13
14
1. Cause or knowingly permit the use of advertisement,
14
15
promotion, solicitation, representation, proposal or offer that is
15
16
untrue, deceptive or misleading;
16
17
2. Charge a pharmacist or pharmacy a fee related to the
17
18
adjudication of a claim including without limitation a fee for:
18
19
a. the submission of a claim,
19
20
b. enrollment or participation in a retail pharmacy
20
21
network, or
21
22
c. the development or management of claims processing
22
23
services or claims payment services related to
23
24
participation in a retail pharmacy network;
24
Req. No. 697 Page 5

1
3. Reimburse a pharmacy or pharmacist in the state an amount
1
2
less than the amount that the PBM reimburses a pharmacy owned by or
2
3
under common ownership with a PBM for providing the same covered
3
4
services. The reimbursement amount paid to the pharmacy shall be
4
5
equal to the reimbursement amount calculated on a per-unit basis
5
6
using the same generic product identifier or generic code number
6
7
paid to the PBM-owned or PBM-affiliated pharmacy;
7
8
4. Deny a provider the opportunity to participate in any
8
9
pharmacy network at preferred participation status if the provider
9
10
is willing to accept the terms and conditions that the PBM has
10
11
established for other providers as a condition of preferred network
11
12
participation status;
12
13
5. Deny, limit or terminate a provider’s contract based on
13
14
employment status of any employee who has an active license to
14
15
dispense, despite probation status, with the State Board of
15
16
Pharmacy;
16
17
6. Retroactively deny or reduce reimbursement for a covered
17
18
service claim after returning a paid claim response as part of the
18
19
adjudication of the claim, unless:
19
20
a. the original claim was submitted fraudulently, or
20
21
b. to correct errors identified in an audit, so long as
21
22
the audit was conducted in compliance with Sections
22
23
356.2 and 356.3 of Title 59 of the Oklahoma Statutes;
23
24
24
Req. No. 697 Page 6

1
7. Fail to make any payment due to a pharmacy or pharmacist for
1
2
covered services properly rendered in the event a PBM terminates a
2
3
provider from a pharmacy benefits manager network;
3
4
8. Fail to make any payment due to a pharmacy or pharmacist for
4
5
covered services properly rendered in the event a PBM terminates its
5
6
contract with a plan sponsor or insurer;
6
7
9. Conduct or practice spread pricing, as defined in Section
7
8
6960 of this title, in this state; or
8
9
9. 10. Charge a pharmacist or pharmacy a fee related to
9
10
participation in a retail pharmacy network including but not limited
10
11
to the following:
11
12
a. an application fee,
12
13
b. an enrollment or participation fee,
13
14
c. a credentialing or re-credentialing fee,
14
15
d. a change of ownership fee, or
15
16
e. a fee for the development or management of claims
16
17
processing services or claims payment services.
17
18
C. The prohibitions under this section shall apply to contracts
18
19
between pharmacy benefits managers and providers for participation
19
20
in retail pharmacy networks.
20
21
1. A PBM contract shall:
21
22
a. not restrict, directly or indirectly, any pharmacy
22
23
that dispenses a prescription drug from informing, or
23
24
penalize such pharmacy for informing, an individual of
24
Req. No. 697 Page 7

1
any differential between the individual’s out-of-
1
2
pocket cost or coverage with respect to acquisition of
2
3
the drug and the amount an individual would pay to
3
4
purchase the drug directly, and
4
5
b. ensure that any entity that provides pharmacy benefits
5
6
management services under a contract with any such
6
7
health plan or health insurance coverage does not,
7
8
with respect to such plan or coverage, restrict,
8
9
directly or indirectly, a pharmacy that dispenses a
9
10
prescription drug from informing, or penalize such
10
11
pharmacy for informing, a covered individual of any
11
12
differential between the individual’s out-of-pocket
12
13
cost under the plan or coverage with respect to
13
14
acquisition of the drug and the amount an individual
14
15
would pay for acquisition of the drug without using
15
16
any health plan or health insurance coverage.
16
17
2. A pharmacy benefits manager’s contract with a provider shall
17
18
not prohibit, restrict, or limit disclosure of information or
18
19
documents to the Attorney General, law enforcement or state and
19
20
federal governmental officials investigating or examining a
20
21
complaint or conducting a review of a pharmacy benefits manager’s
21
22
compliance with the requirements under the Patient’s Right to
22
23
Pharmacy Choice Act, the Pharmacy Audit Integrity Act, and Sections
23
24
357 through 360 of Title 59 of the Oklahoma Statutes.
24
Req. No. 697 Page 8

1
D. A pharmacy benefits manager shall:
1
2
1. Establish and maintain an electronic claim inquiry
2
3
processing system using the National Council for Prescription Drug
3
4
Programs’ current standards to communicate information to pharmacies
4
5
submitting claim inquiries;
5
6
2. Fully disclose to insurers, self-funded employers, unions or
6
7
other PBM clients the existence of the respective aggregate
7
8
prescription drug discounts, rebates received from drug
8
9
manufacturers and pharmacy audit recoupments;
9
10
3. Provide the Attorney General, insurers, self-funded employer
10
11
plans and unions unrestricted audit rights of and access to the
11
12
respective PBM pharmaceutical manufacturer and provider contracts,
12
13
plan utilization data, plan pricing data, pharmacy utilization data
13
14
and pharmacy pricing data;
14
15
4. Maintain, for no less than three (3) years, documentation of
15
16
all network development activities including but not limited to
16
17
contract negotiations and any denials to providers to join networks.
17
18
This documentation shall be made available to the Attorney General
18
19
upon request; and
19
20
5. Report to the Attorney General, on a quarterly basis for
20
21
each health insurer payor, on the following information:
21
22
a. the aggregate amount of rebates received by the PBM,
22
23
b. the aggregate amount of rebates distributed to the
23
24
appropriate health insurer payor,
24
Req. No. 697 Page 9

1
c. the aggregate amount of rebates passed on to the
1
2
enrollees of each health insurer payor at the point of
2
3
sale that reduced the applicable deductible,
3
4
copayment, coinsure or other cost sharing amount of
4
5
the enrollee,
5
6
d. the individual and aggregate amount paid by the health
6
7
insurer payor to the PBM for pharmacy services
7
8
itemized by pharmacy, drug product and service
8
9
provided, and
9
10
e. the individual and aggregate amount a PBM paid a
10
11
provider for pharmacy services itemized by pharmacy,
11
12
drug product and service provided.
12
13
E. Nothing in the Patient’s Right to Pharmacy Choice Act shall
13
14
prohibit the Attorney General from requesting and obtaining detailed
14
15
data, including raw data, in response to the information provided by
15
16
a PBM in the quarterly reports required by this section. The
16
17
Attorney General may alter the frequency of the reports required by
17
18
this section at his or her sole discretion.
18
19
F. The Attorney General may promulgate rules to implement the
19
20
provisions of the Patient’s Right to Pharmacy Choice Act, the
20
21
Pharmacy Audit Integrity Act, and Sections 357 through 360 of Title
21
22
59 of the Oklahoma Statutes.
22
23
23
24
24
Req. No. 697 Page 10

1
SECTION 3. AMENDATORY 36 O.S. 2021, Section 6965, as
1
2
last amended by Section 3, Chapter 306, O.S.L. 2024 (36 O.S. Supp.
2
3
2024, Section 6965), is amended to read as follows:
3
4
Section 6965. A. The Attorney General shall have power and
4
5
authority to examine and investigate the affairs of every pharmacy
5
6
benefits manager (PBM) engaged in pharmacy benefits management in
6
7
this state in order to determine whether such entity is in
7
8
compliance with the Patient’s Right to Pharmacy Choice Act, the
8
9
Pharmacy Audit Integrity Act, and Sections 357 through 360 of Title
9
10
59 of the Oklahoma Statutes.
10
11
B. The Attorney General shall have the power and authority to
11
12
subpoena witnesses and records, whether prior to or during an
12
13
investigation or prosecution of a complaint, from any relevant
13
14
entity or persons to ensure compliance with the Patient’s Right to
14
15
Pharmacy Choice Act, the Pharmacy Audit Integrity Act, and Sections
15
16
357 through 360 of Title 59 of the Oklahoma Statutes.
16
17
C. All PBM files and records shall be subject to examination by
17
18
the Attorney General or by duly appointed designees. The Attorney
18
19
General, authorized employees and examiners shall have access to any
19
20
of a PBM’s files and records that may relate to a particular
20
21
complaint under investigation or to an inquiry or examination by the
21
22
Attorney General.
22
23
D. Every officer, director, employee or agent of the PBM, upon
23
24
receipt of any inquiry from the Attorney General, shall, within
24
Req. No. 697 Page 11

1
twenty (20) days from the date the inquiry is sent, furnish the
1
2
Attorney General with an adequate response to the inquiry.
2
3
E. When making an examination under this section, the Attorney
3
4
General may retain subject matter experts, attorneys, appraisers,
4
5
independent actuaries, independent certified public accountants or
5
6
an accounting firm or individual holding a permit to practice public
6
7
accounting, certified financial examiners or other professionals and
7
8
specialists as examiners, the cost of which shall be borne by the
8
9
PBM that is the subject of the examination.
9
10
F. 1. Protected health information (PHI) held by a PBM shall
10
11
be provided at the request of the Attorney General for the purpose
11
12
of conducting investigations into potential violations of state laws
12
13
and regulations related to the PBM. Disclosure of protected health
13
14
information shall be limited to the extent necessary for the
14
15
investigation and enforcement of state law.
15
16
2. All disclosures of protected health information shall be
16
17
made in compliance with all applicable federal and state privacy
17
18
laws, including the Health Insurance Portability and Accountability
18
19
Act of 1996 (HIPAA), and other relevant laws protecting the privacy
19
20
and confidentiality of health information.
20
21
3. Any protected health information obtained for an
21
22
investigation shall be handled and maintained per applicable federal
22
23
and state privacy laws and regulations, including HIPAA.
23
24
24
Req. No. 697 Page 12

1
4. Unauthorized disclosure of protected health information
1
2
obtained during an investigation is strictly prohibited and subject
2
3
to legal penalties.
3
4
G. 1. If the Attorney General, after notice and opportunity
4
5
for hearing, finds that any PBM operating within this state has not
5
6
fully cooperated with an investigation or inquiry conducted by the
6
7
Attorney General related to compliance with the Patient’s Right to
7
8
Pharmacy Choice Act, the Pharmacy Audit Integrity Act, and Sections
8
9
357 through 360 of Title 59 of the Oklahoma Statutes, the Attorney
9
10
General may instruct the Insurance Commissioner that the PBM be
10
11
censured or his or her license be suspended or revoked. If the
11
12
Attorney General makes such instruction, the Commissioner shall
12
13
enforce the instructed action within thirty (30) days.
13
14
2. In addition to or in lieu of any censure, suspension, or
14
15
revocation by the Commissioner, the Attorney General may levy a
15
16
civil or administrative fine not less than One Hundred Dollars
16
17
($100.00) and not greater than Ten Thousand Dollars ($10,000.00) for
17
18
each violation of this subsection and assess any other penalty or
18
19
remedy authorized by this act. For purposes of this section, each
19
20
day a PBM fails to comply with an investigation or inquiry may be
20
21
considered a separate violation.
21
22
H. The proper venue to compel compliance with a subpoena of a
22
23
person or entity under this section shall be in the Oklahoma County
23
24
District Court.
24
Req. No. 697 Page 13

1
I. No provision of this state’s law shall be construed to
1
2
prohibit the Attorney General from obtaining any information or
2
3
documentation pertaining to prescription drug transactions
3
4
including, but not limited to, data, statements, testimonies,
4
5
contracts, communications, provider manuals, or any other
5
6
documentation or materials, whether related to discount programs,
6
7
loyalty programs, or otherwise. The duty to provide cooperation as
7
8
set forth in this section shall extend to all PBMs, insurers,
8
9
auditors, employers, vendors, or any other individual or entity
9
10
acting on behalf of or in collaboration with a PBM.
10
11
SECTION 4. This act shall become effective November 1, 2025.
11
12
12
13
60-1-697 CAD 1/19/2025 5:43:03 AM
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
21
21
22
22
23
23
24
24
Req. No. 697 Page 14

[DELETED:  P B G]
[DELETED:  P]
[DELETED:  P c a c]
[DELETED:  P]
[DELETED:  P n p m t e t]
[DELETED:  P t t]
[DELETED:  P a a a a a n]
[DELETED:  P e]
[DELETED:  P t t]
[DELETED:  P t t t]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P C 1]